Poster

Premature Ejaculation, And The Phycological Impact Of Majority Of Female Sexual Dysfunction

We aim to investigate the elevated occurrence of Female Orgasmic Disorder (FOD) within our patient population, attributable to male sexual dysfunction (MSD) in their partners. Through a c...

Milo Obas , BS, EMT;

10/26/2023

Population Pharmacokinetics for Switching From Oral or Long-Acting Injectable Risperidone to RYKINDO® (Risperidone) for Extended-Release Injectable Suspension, a Novel Long-Acting Injectable, in Patients With Schizophrenia

In adult patients with schizophrenia, switching from RISPERDAL CONSTA® (RC) to RYKINDO® requires administration of the first RYKINDO injection 4-5 weeks after the last RC injection. For p...

Ying Dong , MD, PhD;

10/26/2023

Practice Patterns in Schizophrenia Diagnosis and Management: Identifying Gaps in Clinician Knowledge

Clinicians are challenged to diagnose, assess, and treat patients with schizophrenia. This CME based survey assessed current practice gaps among US based psychiatrists related to the diag...

Natalie Guevara , DVM, MPH;

10/26/2023

Precision Medicine and Target-Controlled Infusions Significantly Improves the Efficacy of Ketamine Therapy for Treatment-Resistant Depression

Precision Medicine and Target-Controlled Infusions (TCI) represent a novel methodology to enhance the effectiveness and durability of ketamine infusion therapy for treatment-resistant dep...

Gerald Grass ;

10/26/2023

Pharmaceutical Pipeline of BI 1358894: Clinical Evidence for an Emerging Drug for the Treatment of Mental Health Conditions

Dysregulated emotional processing and overwhelming negative emotions are core symptoms of disorders such as posttraumatic stress disorder (PTSD) and major depressive disorder (MDD) and ar...

Talal Al Habbab , PharmD;

10/26/2023

Pharmacogenomic Testing in Depression Care: Can Curriculum Based Online Education Improve Provider Knowledge, Competence, and Confidence?

Many clinicians are unaware of the evidence for pharmacogenomic (PGx) testing in depression care and are uncertain as to how to incorporate this modality into clinical decision making. Th...

Natalie Guevara , DVM, MPH;

10/26/2023

Pharmacokinetic Simulations of Aripiprazole 2-Month Ready-To-Use Long-Acting Injectable to Inform Administration in Adult Patients With Schizophrenia or Bipolar-I Disorder

Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU 960) is a novel long-acting injectable formulation of aripiprazole for gluteal administration once every 2 months. Simulations conducte...

Matthew Harlin , MD, MS;

10/26/2023

Pharmacokinetics and Safety of RYKINDO® (Risperidone) for Extended-Release Injectable Suspension, a Novel Long-Acting Injectable Risperidone, in Patients With Schizophrenia and/or Schizoaffective Disorder

This randomized, open-label, relative bioavailability study comparatively evaluated the pharmacokinetics and safety of RYKINDO®, a novel long-acting risperidone administered biweekly (Q2W...

Ying Dong , MD, PhD;

10/26/2023

Physician Assistants/Associates Burnout and Intention to Leave Principal Clinical Position: A National Cross-Sectional Analysis

We undertook a national study to evaluate and quantify burnout levels among the PA workforce. The study’s findings highlight that approximately a third of PAs experience at least one symp...

Mirela Bruza-Augatis , MS, PA-C;

10/26/2023

Physician Perspective on Idiopathic Hypersomnia: Awareness, Diagnosis, and Impact on Patients

This online survey assessed US physicians’ familiarity with idiopathic hypersomnia and understanding of the diagnostic process and impact on patients’ lives. Most physicians agreed idiopa...

Marisa Whalen , PharmD;

10/26/2023